Microbiological Profile of Post-COVID-19 Mucormycosis in Various Samples
Background and aim: Increase in fungal superinfections among post-COVID-19 patients created a panic during pandemic times in India. Rhino-orbital mucormycosis cases have seen a rise in India among COVID-19 patients. This study aims and objectives to know the Incidence of Mucormycosis among COVID-19...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS)
2022-06-01
|
| Series: | International Journal of Scientific Research in Dental and Medical Sciences |
| Subjects: | |
| Online Access: | http://www.ijsrdms.com/article_151676_f44fae8774bd9eddbcba223689a9ade8.pdf |
| Summary: | Background and aim: Increase in fungal superinfections among post-COVID-19 patients created a panic during pandemic times in India. Rhino-orbital mucormycosis cases have seen a rise in India among COVID-19 patients. This study aims and objectives to know the Incidence of Mucormycosis among COVID-19 infected patients and the age and sex distribution of Post COVID-19 Mucormycosis patients.
Material and methods: All clinical specimens were received at the Microbiology department from respective hospital units in sterile normal saline leak-proof containers. Fungal cultures were followed until growth occurred or till 28 days. Macroscopic and microscopic characteristics identified positive culture fungal growth.
Results: Out of 97 post covid fungal infection patients in this study, 33 (34.02%) were female, and 64 (65.9%) were male. Predominant populations were in the age group of 41 - 60; it was 60 out of 97 (61.8%), followed by 61-71 years (24.7%). Out of 97 fungal pathogens, Mucor, Aspergillus, and Mucor fungi were isolated predominantly; it was 32 (32.9%), 29 (29.8%), 16 (16.4%), and 11 (11.3%), respectively.
Conclusions: Early Diagnosis and treatment will help manage SARS-CoV-2-associated fungal infections. The formulation of stringent infection control protocols, antimicrobial usage policy, and updated COVID-19 management guidelines by government authorities helps reduce infections. |
|---|---|
| ISSN: | 2676-5497 2676-5373 |